Baylis Medical Technologies Signs Distribution Agreement with Oscor

Wednesday, November 02, 2022

Baylis Medical Technologies Inc. is pleased to announce it is assuming responsibility for the sales and distribution of the Steerable and Guiding Sheaths currently sold direct-to-hospital by Oscor in the United States.

The addition of Oscor's sheath portfolio will allow Baylis Medical Technologies to broaden its clinical solution offerings in radiology and vascular surgery. This builds upon the company's longstanding history of delivering high-quality medical products to patients globally.

"This strategic partnership will allow Baylis Medical Technologies to expand our vascular footprint in the United States. It will strengthen our ability to provide current and future customers with dedicated clinical solutions that enable endovascular and other therapies," says Kris Shah, president of Baylis Medical Technologies.

Baylis Medical Technologies is committed to the conception, development, production, and distribution of state-of-the-art medical products that improve the lives of people around the world. The sheath portfolio will complement the company's existing product offerings, including the PowerWire® RF Guidewire which utilizes radiofrequency technology, and will ultimately enhance the companies' efforts to meet clinical needs of radiologists and vascular surgeons for improved patient care.

Oscor and BMT have begun the transfer of the business and will continue working closely together to ensure the transition has minimal impact on customers.

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO SummitHealthcare CMO Summit